These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 11036833

  • 1. Large macrophage colony-forming cells identical to high proliferative potential colony-forming cells in peripheral blood of patients with collagen vascular diseases: high occurrence among patients with systemic sclerosis and dermatomyositis.
    Horie S, Minota S, Kano S.
    J Rheumatol; 2000 Oct; 27(10):2378-81. PubMed ID: 11036833
    [Abstract] [Full Text] [Related]

  • 2. Detection of large macrophage colony forming cells in the peripheral blood of patients with rheumatoid arthritis.
    Horie S, Nakada K, Masuyama J, Yoshio T, Minota S, Wakabayashi Y, Hirose S, Kano S.
    J Rheumatol; 1997 Aug; 24(8):1517-21. PubMed ID: 9263144
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Identification of activated cytokine pathways in the blood of systemic lupus erythematosus, myositis, rheumatoid arthritis, and scleroderma patients.
    Higgs BW, Zhu W, Richman L, Fiorentino DF, Greenberg SA, Jallal B, Yao Y.
    Int J Rheum Dis; 2012 Feb; 15(1):25-35. PubMed ID: 22324944
    [Abstract] [Full Text] [Related]

  • 5. [Nation-wide survey for the treatment with cyclosporin A of interstitial pneumonia associated with collagen diseases].
    Harigai M, Hara M, Kamatani N, Kashiwazaki S.
    Ryumachi; 1999 Dec; 39(6):819-28. PubMed ID: 10695405
    [Abstract] [Full Text] [Related]

  • 6. Tumor-associated antigens in systemic sclerosis and systemic lupus erythematosus: associations with organ manifestations, immunolaboratory markers and disease activity indices.
    Szekanecz E, Szucs G, Szekanecz Z, Tarr T, Antal-Szalmás P, Szamosi S, Szántó J, Kiss E.
    J Autoimmun; 2008 Dec; 31(4):372-6. PubMed ID: 18926664
    [Abstract] [Full Text] [Related]

  • 7. Decreased levels of autoantibody against histone deacetylase 3 in patients with systemic sclerosis.
    Kuwatsuka Y, Ogawa F, Iwata Y, Komura K, Muroi E, Hara T, Takenaka M, Shimizu K, Hasegawa M, Fujimoto M, Sato S.
    Autoimmunity; 2009 Feb; 42(2):120-5. PubMed ID: 19021012
    [Abstract] [Full Text] [Related]

  • 8. Circulating endothelial progenitor cells in systemic sclerosis: association with disease severity.
    Avouac J, Juin F, Wipff J, Couraud PO, Chiocchia G, Kahan A, Boileau C, Uzan G, Allanore Y.
    Ann Rheum Dis; 2008 Oct; 67(10):1455-60. PubMed ID: 18174219
    [Abstract] [Full Text] [Related]

  • 9. Patients with systemic lupus erythematosus, myositis, rheumatoid arthritis and scleroderma share activation of a common type I interferon pathway.
    Higgs BW, Liu Z, White B, Zhu W, White WI, Morehouse C, Brohawn P, Kiener PA, Richman L, Fiorentino D, Greenberg SA, Jallal B, Yao Y.
    Ann Rheum Dis; 2011 Nov; 70(11):2029-36. PubMed ID: 21803750
    [Abstract] [Full Text] [Related]

  • 10. Abnormal DNA methylation in CD4+ T cells from patients with systemic lupus erythematosus, systemic sclerosis, and dermatomyositis.
    Lei W, Luo Y, Lei W, Luo Y, Yan K, Zhao S, Li Y, Qiu X, Zhou Y, Long H, Zhao M, Liang Y, Su Y, Lu Q.
    Scand J Rheumatol; 2009 Nov; 38(5):369-74. PubMed ID: 19444718
    [Abstract] [Full Text] [Related]

  • 11. Serum concentrations of the CXC chemokines interleukin 8 and growth-regulated oncogene-alpha are elevated in patients with systemic sclerosis.
    Furuse S, Fujii H, Kaburagi Y, Fujimoto M, Hasegawa M, Takehara K, Sato S.
    J Rheumatol; 2003 Jul; 30(7):1524-8. PubMed ID: 12858452
    [Abstract] [Full Text] [Related]

  • 12. Nail changes in connective tissue diseases: do nail changes provide clues for the diagnosis?
    Tunc SE, Ertam I, Pirildar T, Turk T, Ozturk M, Doganavsargil E.
    J Eur Acad Dermatol Venereol; 2007 Apr; 21(4):497-503. PubMed ID: 17373977
    [Abstract] [Full Text] [Related]

  • 13. Risk factors for Pneumocystis carinii pneumonia in patients with polymyositis/dermatomyositis or systemic lupus erythematosus.
    Kadoya A, Okada J, Iikuni Y, Kondo H.
    J Rheumatol; 1996 Jul; 23(7):1186-8. PubMed ID: 8823690
    [Abstract] [Full Text] [Related]

  • 14. Serum soluble Fas levels in patients with autoimmune rheumatic diseases.
    Sahin M, Aydintug O, Tunc SE, Tutkak H, Naziroğlu M.
    Clin Biochem; 2007 Jan; 40(1-2):6-10. PubMed ID: 17056024
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Phenotypical and functional characteristics of in vitro expanded bone marrow mesenchymal stem cells from patients with systemic sclerosis.
    Larghero J, Farge D, Braccini A, Lecourt S, Scherberich A, Foïs E, Verrecchia F, Daikeler T, Gluckman E, Tyndall A, Bocelli-Tyndall C.
    Ann Rheum Dis; 2008 Apr; 67(4):443-9. PubMed ID: 17526552
    [Abstract] [Full Text] [Related]

  • 17. Reduced T lymphoid colony growth in patients with progressive systemic sclerosis and rheumatoid arthritis.
    Winkelstein A, Bernstein ML, Stevens MA, Rodnan GP, Medsger TA, Dobson SA.
    J Lab Clin Med; 1982 Aug; 100(2):240-7. PubMed ID: 6980249
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. OxLDL/beta2GPI complexes and autoantibodies in patients with systemic lupus erythematosus, systemic sclerosis, and antiphospholipid syndrome: pathogenic implications for vascular involvement.
    Lopez LR, Simpson DF, Hurley BL, Matsuura E.
    Ann N Y Acad Sci; 2005 Jun; 1051():313-22. PubMed ID: 16126973
    [Abstract] [Full Text] [Related]

  • 20. Increased interleukin-17 production in patients with systemic sclerosis.
    Kurasawa K, Hirose K, Sano H, Endo H, Shinkai H, Nawata Y, Takabayashi K, Iwamoto I.
    Arthritis Rheum; 2000 Nov; 43(11):2455-63. PubMed ID: 11083268
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.